Literature DB >> 2241232

Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

A Greenough1.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2241232      PMCID: PMC1590250          DOI: 10.1136/adc.65.10_spec_no.1082

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  59 in total

1.  Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.

Authors:  R A Wilkie; M H Bryan
Journal:  J Pediatr       Date:  1987-08       Impact factor: 4.406

2.  Improved prognosis of infants mechanically ventilated for hyaline membrane disease.

Authors:  E O Reynolds; A Taghizadeh
Journal:  Arch Dis Child       Date:  1974-07       Impact factor: 3.791

3.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

Review 4.  Bronchopulmonary dysplasia.

Authors:  E Bancalari; T Gerhardt
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

5.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

Authors:  M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

6.  Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.

Authors:  B Engelhardt; S Elliott; T A Hazinski
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

7.  Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.

Authors:  J P Shenai; K A Kennedy; F Chytil; M T Stahlman
Journal:  J Pediatr       Date:  1987-08       Impact factor: 4.406

8.  The therapeutic actions of theophylline in preterm ventilated infants.

Authors:  A Greenough; A Elias-Jones; J Pool; C J Morley; J A Davis
Journal:  Early Hum Dev       Date:  1985-10       Impact factor: 2.079

9.  Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  P R Durie; G G Forstner; K J Gaskin; D J Moore; G J Cleghorn; S S Wong; M L Corey
Journal:  Pediatr Res       Date:  1986-03       Impact factor: 3.756

10.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

View more
  10 in total

1.  Positive end expiratory pressure in acute and chronic respiratory distress.

Authors:  A Greenough; V Chan; M F Hird
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

2.  Sonographic prediction of chronic lung disease in the premature undergoing mechanical ventilation.

Authors:  E F Avni; M Cassart; V de Maertelaer; F Rypens; D Vermeylen; P A Gevenois
Journal:  Pediatr Radiol       Date:  1996-07

3.  Longitudinal assessment of infant lung function following pregnancies complicated by prolonged and preterm rupture of the membranes.

Authors:  P Thompson; A Greenough; K H Nicolaides
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

4.  Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis.

Authors:  J D Corcoran; C C Patterson; P S Thomas; H L Halliday
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

5.  Effect of chronic lung disease on blood pressure levels at follow up.

Authors:  A Greenough; E F Emery
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

6.  Bronchopulmonary dysplasia in infants with respiratory distress syndrome in a developing country: a prospective single centre-based study.

Authors:  J Smith; S Kling; R P Gie; J van Zyl; G F Kirsten; E D Nel; J W Schneider
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

7.  Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors:  S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

8.  Effect of dexamethasone on blood pressure--relationship to postnatal age.

Authors:  E F Emery; A Greenough
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

9.  Adrenocortical function and chronic lung disease of pre-maturity: an unresolved problem?

Authors:  C Romagnoli; C Latella; E Zecca; P Papacci; G Tortorolo
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

10.  Ipratropium bromide for symptomatic preterm infants.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.